PI3K/Akt/mTOR signalling pathway activation in patients with ER‑positive, metachronous, contralateral breast cancer treated with hormone therapyHirofumi Kanaizumi, Yoshifumi Komoike|Oncology Letters|2018Cited by 16
PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapyHirofumi Kanaizumi, Y. Komoike|European Journal of Cancer|2018Cited by 13